In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Sosei floats on TSE in oversubscribed IPO

Executive Summary

In an oversubscribed IPO, Sosei has grossed Y11.3bn ($104.5mm) with the sale of 14.05k shares at Y800k each. It will list on the Tokyo Stock Exchange's market of the high-growth and emerging stocks (MOTHERS) with a market cap in excess of Y55bn.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

UsernamePublicRestriction

Register